Athersys Inc (ATHXQ)
0.004
0.00 (0.00%)
USD |
OTCM |
Jun 17, 15:56
Athersys Enterprise Value: 10.05M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 10.05M |
| June 13, 2024 | 10.01M |
| June 12, 2024 | 10.01M |
| June 11, 2024 | 10.01M |
| June 10, 2024 | 10.06M |
| June 07, 2024 | 10.06M |
| June 06, 2024 | 10.08M |
| June 05, 2024 | 10.02M |
| June 04, 2024 | 10.04M |
| June 03, 2024 | 10.14M |
| May 31, 2024 | 10.14M |
| May 30, 2024 | 10.03M |
| May 29, 2024 | 10.07M |
| May 28, 2024 | 10.03M |
| May 24, 2024 | 10.07M |
| May 23, 2024 | 10.05M |
| May 22, 2024 | 10.06M |
| May 21, 2024 | 10.06M |
| May 20, 2024 | 10.03M |
| May 17, 2024 | 10.05M |
| May 16, 2024 | 10.01M |
| May 15, 2024 | 10.04M |
| May 14, 2024 | 10.04M |
| May 13, 2024 | 10.05M |
| May 10, 2024 | 10.02M |
| Date | Value |
|---|---|
| May 09, 2024 | 10.02M |
| May 08, 2024 | 10.06M |
| May 07, 2024 | 10.05M |
| May 06, 2024 | 10.04M |
| May 03, 2024 | 10.03M |
| May 02, 2024 | 10.02M |
| May 01, 2024 | 10.02M |
| April 30, 2024 | 10.10M |
| April 29, 2024 | 9.987M |
| April 26, 2024 | 10.04M |
| April 25, 2024 | 10.04M |
| April 24, 2024 | 10.04M |
| April 23, 2024 | 10.05M |
| April 22, 2024 | 10.06M |
| April 19, 2024 | 10.04M |
| April 18, 2024 | 9.969M |
| April 17, 2024 | 10.01M |
| April 16, 2024 | 10.02M |
| April 15, 2024 | 10.04M |
| April 12, 2024 | 10.06M |
| April 11, 2024 | 10.14M |
| April 10, 2024 | 10.07M |
| April 09, 2024 | 10.12M |
| April 08, 2024 | 10.17M |
| April 05, 2024 | 10.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.572M
Minimum
Nov 09 2022
646.97M
Maximum
Apr 01 2020
166.39M
Average
161.80M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
| Theriva Biologics Inc | -10.87M |
| Oragenics Inc | 6.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.771M |
| Total Expenses (Quarterly) | 7.78M |
| EPS Diluted (Quarterly) | -0.15 |
| Earnings Yield | -50.75K% |
| Normalized Earnings Yield | -75750.00 |